Tumor-induced host immunosuppression: Special focus on CLL

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Malignant cells are able to suppress host immune responses in an effort to avoid immune detection in vivo. Tumor-induced immunosuppression can be achieved at the molecular, cellular, and/or physiological levels. Herein the contribution of immune-tolerant genes and regulatory cells to immunosuppression related to alterations of T-cells and antigen-presentation is reviewed. Furthermore, key advances in countering tumorinduced immunosuppression are described in reference to immune evasion mechanisms used by chronic lymphocytic leukemia (CLL) cells. Lastly, the challenges associated with targeting the tumor microenvironment coupled with the usefulness of immunomodulatory drugs are discussed. This review summarizes select immune evasion tactics orchestrated by the conversation between CLL cells and their microenvironment.

Original languageEnglish (US)
Pages (from-to)35-41
Number of pages7
JournalInternational Immunopharmacology
Volume17
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Immunosuppression
Immune Evasion
Cellular Microenvironment
Neoplasms
Tumor Microenvironment
Viral Tumor Antigens
Antigen Presentation
Regulator Genes
T-Lymphocytes
Pharmaceutical Preparations

Keywords

  • Chronic lymphocytic leukemia
  • Immune effector cells
  • Immune surveillance
  • Suppressor cells
  • Tumor-induced immunosuppression

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Tumor-induced host immunosuppression : Special focus on CLL. / Cutucache, Christine E.

In: International Immunopharmacology, Vol. 17, No. 1, 01.01.2013, p. 35-41.

Research output: Contribution to journalReview article

@article{5d82ee2cb84c459fb0d538517c00985e,
title = "Tumor-induced host immunosuppression: Special focus on CLL",
abstract = "Malignant cells are able to suppress host immune responses in an effort to avoid immune detection in vivo. Tumor-induced immunosuppression can be achieved at the molecular, cellular, and/or physiological levels. Herein the contribution of immune-tolerant genes and regulatory cells to immunosuppression related to alterations of T-cells and antigen-presentation is reviewed. Furthermore, key advances in countering tumorinduced immunosuppression are described in reference to immune evasion mechanisms used by chronic lymphocytic leukemia (CLL) cells. Lastly, the challenges associated with targeting the tumor microenvironment coupled with the usefulness of immunomodulatory drugs are discussed. This review summarizes select immune evasion tactics orchestrated by the conversation between CLL cells and their microenvironment.",
keywords = "Chronic lymphocytic leukemia, Immune effector cells, Immune surveillance, Suppressor cells, Tumor-induced immunosuppression",
author = "Cutucache, {Christine E.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.intimp.2013.05.021",
language = "English (US)",
volume = "17",
pages = "35--41",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Tumor-induced host immunosuppression

T2 - Special focus on CLL

AU - Cutucache, Christine E.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Malignant cells are able to suppress host immune responses in an effort to avoid immune detection in vivo. Tumor-induced immunosuppression can be achieved at the molecular, cellular, and/or physiological levels. Herein the contribution of immune-tolerant genes and regulatory cells to immunosuppression related to alterations of T-cells and antigen-presentation is reviewed. Furthermore, key advances in countering tumorinduced immunosuppression are described in reference to immune evasion mechanisms used by chronic lymphocytic leukemia (CLL) cells. Lastly, the challenges associated with targeting the tumor microenvironment coupled with the usefulness of immunomodulatory drugs are discussed. This review summarizes select immune evasion tactics orchestrated by the conversation between CLL cells and their microenvironment.

AB - Malignant cells are able to suppress host immune responses in an effort to avoid immune detection in vivo. Tumor-induced immunosuppression can be achieved at the molecular, cellular, and/or physiological levels. Herein the contribution of immune-tolerant genes and regulatory cells to immunosuppression related to alterations of T-cells and antigen-presentation is reviewed. Furthermore, key advances in countering tumorinduced immunosuppression are described in reference to immune evasion mechanisms used by chronic lymphocytic leukemia (CLL) cells. Lastly, the challenges associated with targeting the tumor microenvironment coupled with the usefulness of immunomodulatory drugs are discussed. This review summarizes select immune evasion tactics orchestrated by the conversation between CLL cells and their microenvironment.

KW - Chronic lymphocytic leukemia

KW - Immune effector cells

KW - Immune surveillance

KW - Suppressor cells

KW - Tumor-induced immunosuppression

UR - http://www.scopus.com/inward/record.url?scp=84879041234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879041234&partnerID=8YFLogxK

U2 - 10.1016/j.intimp.2013.05.021

DO - 10.1016/j.intimp.2013.05.021

M3 - Review article

C2 - 23751895

AN - SCOPUS:84879041234

VL - 17

SP - 35

EP - 41

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 1

ER -